녹내장 수술용 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 수술 방법별, 최종 용도별, 부문별 예측(2023-2030년)

Glaucoma Surgery Devices Market Size, Share & Trends Analysis Report By Product (Laser Systems, Diamond Knives), By Surgery Method (MIGS, Laser Surgery), By End-use (Hospitals, Ophthalmic Clinics), And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,401,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,813,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,637,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

녹내장 수술용 기기 시장의 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 녹내장 수술 기기 시장은 2023년부터 2030년까지 연평균 4.61%의 CAGR을 기록하며 2030년에는 22억 7,000만 달러에 달할 것으로 예상됩니다.

녹내장의 세계 부담 증가는 예측 기간 동안 시장 성장에 기여할 것으로 보입니다. 또한, 유리한 상환 정책 및 외국인 직접 투자 조항과 같은 정부 지원은 특히 신흥 시장에서 시장 성장을 촉진할 것으로 예상됩니다. 최소침습적 녹내장 수술(MIGS)에 대한 수요 증가는 예측 기간 동안 첨단 녹내장 수술 기기에 대한 수요를 촉진할 것으로 예상됩니다.

정부와 비영리단체는 녹내장과 그 치료에 사용되는 수술에 대한 지식을 높이기 위해 여러 캠페인을 시작했습니다. 이러한 노력은 최첨단 수술법에 대한 수요 증가로 이어질 것으로 예상됩니다. 또한, 정교하고 최소침습적인 수술법에 대한 소비자의 선호도 변화도 시장 확대에 긍정적인 영향을 미칠 것으로 예상됩니다. 또한, 녹내장 치료에서 약물 치료보다 수술적 치료의 채택률이 높다는 점이 향후 시장 성장을 견인할 것으로 예상됩니다. 외용제를 포함한 전통적인 녹내장 치료법은 레이저 수술에 이어 1차 선택 치료법으로 간주됩니다.

미국 국립의학도서관(NCBI)에 따르면, 2018년 녹내장 진단을 받은 환자에게 약 4만 건의 MIGS 수술이 시행됐습니다. 이 최소 침습 수술은 입원 기간을 단축하고 환자가 병원 내 감염에 걸릴 확률을 낮출 수 있습니다. 또한, 입원 기간이 짧아짐에 따라 환자들은 더 빨리 일상으로 복귀할 수 있습니다. 첨단 장비의 빈번한 출시도 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 4월 존슨앤드존슨 비전은 라식 플랩 개발용 펨토세컨드 레이저 '엘리타(ELITA)'의 미국 FDA 510(k) 승인을 받았습니다.

녹내장 수술용 기기 시장 보고서 하이라이트

• 제품별로는 전통적인 녹내장 수술에 대한 선호도가 높기 때문에 전통적인 수술용 기기 부문이 2022년 40% 이상의 점유율을 차지하며 시장을 장악했습니다.
• 수술 방법에 따라 전통적인 녹내장 수술 부문은 효율성으로 인해 2022년 35.11%의 가장 큰 시장 점유율을 차지했습니다.
• 안과 클리닉 최종 용도 부문은 안과 및 기타 관련 질환을 앓고 있는 환자 수가 증가함에 따라 예측 기간 동안 가장 빠른 CAGR 4.80%로 확대될 것으로 예상됩니다.
• 북미는 2022년 37.26%로 가장 큰 점유율을 차지했으며, 예측 기간 동안 건전한 CAGR로 확대될 것으로 예상됩니다.
• 아시아태평양은 주요 기업의 존재와 당뇨병 유병률 증가로 인해 예측 기간 동안 가장 빠르게 성장하는 지역 시장이 될 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 녹내장 수술용 기기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 보급과 성장 전망 매핑
• 업계의 밸류체인 분석
  • 상환 체계
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 녹내장 수술용 기기 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 주요 거래와 전략적 제휴 분석
  • 시장 진출 전략

제4장 녹내장 수술용 기기 시장 : 제품 추정·동향 분석

• 정의와 범위
• 제품 시장 점유율, 2018년과 2030년
• 부문 대시보드
• 제품별 세계의 녹내장 수술용 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년에서 2030년까지

제5장 녹내장 수술용 기기 시장 : 수술 방법 추정·동향 분석

• 정의와 범위
• 수술 방법 시장 점유율, 2018년과 2030년
• 부문 대시보드
• 수술 방법별 세계의 녹내장 수술용 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년에서 2030년까지

제6장 녹내장 수술용 기기 시장 : 최종 용도 추정·동향 분석

• 정의와 범위
• 최종 용도 시장 점유율, 2018년 및 2030년
• 부문 대시보드
• 최종 용도별 세계 녹내장 수술용 기기 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018년에서 2030년까지

제7장 녹내장 수술용 기기 시장 : 지역 추정·동향 분석

• 지역 시장 점유율 분석, 2022년 및 2030년
• 지역 시장 대시보드
• 세계의 지역 시장 현황
• 지역 시장 점유율과 주요 기업, 2022년
• 시장 응용, 예측 및 동향 분석, 2018년에서 2030년 :
• 북미
  • 시장 추정과 예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 인도
  • 중국
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 상황

• 주요 시장 진출 기업에 의한 최근의 동향과 영향 분석
• 회사/경쟁 분류
  • 이노베이터
• 벤더 상황
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2022
  • Alcon, Inc.
  • Glaukos Corporation
  • Johnson &Johnson Vision
  • AbbVie Inc.(Allergan Plc.)
  • ASICO, LLC
  • Carl Zeiss Meditec AG
  • Katalyst Surgical
  • Lumenis Ltd
  • Ziemer Ophthalmic Systems AG
  • Iridex Corporation
  • Altomed

ksm

영문 목차

영문목차

Glaucoma Surgery Devices Market Growth & Trends:

The global glaucoma surgery devices market is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.61% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The rising global burden of glaucoma is expected to contribute to market growth over the forecast period. In addition, government support, such as favorable reimbursement policies and foreign direct investment provisions, is expected to drive market growth, especially in developing regions. Rising demand for Minimally Invasive Glaucoma Surgery (MIGS) procedures is expected to drive the demand for advanced glaucoma surgery devices over the forecast period.

The government and non-profit organizations have launched several campaigns to raise knowledge about glaucoma and the procedures used to treat it. These efforts are expected to help increase the demand for cutting-edge surgical methods. In addition, a shift in consumer preference toward sophisticated minimally invasive surgical procedures is anticipated to positively affect market expansion. Moreover, the high adoption of surgical treatment over medications for the treatment of glaucoma is expected to boost the market growth in the near future. The traditional way of glaucoma therapy involving topical medications is considered first-line treatment followed by laser surgery.

The development of new procedures, such as MIGS, creates new growth opportunities in the market.According to the National Library of Medicine (NCBI), approximately 40,000 MIGS surgical procedures were performed in patients diagnosed with glaucoma in 2018. This minimally invasive surgery can reduce hospital stays, lowering the chance of patients contracting hospital-acquired infections. Shorter hospital stays also enable patients to return to their normal lives quicker. Frequent launches of advanced devices are also expected to fuel market growth during the forecast period. For instance, in April 2023, Johnson & Johnson Vision received the U.S. FDA 510 (k) clearance for its ELITA Femtosecond laser for the development of LASIK flaps.

Glaucoma Surgery Devices Market Report Highlights:

• By product, the traditional surgery devices segment dominated the market by capturing a share of over 40% in 2022 owing to the high preference for traditional glaucoma surgery
• Based on surgery method, the traditional glaucoma surgery segment held the largest market share of 35.11% in 2022 owing to its efficiency
• The ophthalmic clinics end-use segment is expected to expand at the fastest CAGR of 4.80% over the forecast period attributed to the rising number of patients suffering from ophthalmic and other related disorders
• North America held the largest share of 37.26% in 2022 and is expected to expand at a healthy CAGR over the forecast period
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the presence of key players and the increasing prevalence of diabetes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Surgery Method
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Surgery Method outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Glaucoma Surgery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Rising geriatric population
    • 3.4.1.2. Growing adoption of surgical treatments for glaucoma
    • 3.4.1.3. Rising number of government and non-government glaucoma care initiatives
    • 3.4.1.4. Growing prevalence of diabetes
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Availability of alternative treatment methods
    • 3.4.2.2. Lack of awareness about glaucoma and its treatment procedures in underdeveloped countries
• 3.5. Glaucoma Surgery Devices Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Glaucoma Surgery Devices Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Glaucoma Drainage Devices
    • 4.1.1.1. Valves
    • 4.1.1.2. Glaucoma Drainage Implant
    • 4.1.1.3. Glaucoma Tube Shunts
    • 4.1.1.4. Stents
  • 4.1.2. Traditional Surgery Devices
    • 4.1.2.1. Scalpel
    • 4.1.2.2. Forceps
    • 4.1.2.3. Ophthalmic Scissors
    • 4.1.2.4. Punch
    • 4.1.2.5. Sutures
    • 4.1.2.6. Surgical Drapes
    • 4.1.2.7. Microcatheter
    • 4.1.2.8. Others
  • 4.1.3. Diamond Knives
  • 4.1.4. Laser Systems
  • 4.1.5. Others
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Glaucoma Surgery Devices Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Glaucoma Drainage Devices
    • 4.5.1.1. Glaucoma drainage devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Valves
    • 4.5.1.2.1. Valves market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Glaucoma Drainage Implant
    • 4.5.1.3.1. Glaucoma draingae implant market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.4. Glaucoma Tube Shunts
    • 4.5.1.4.1. Glaucoma tube shunts market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5. Stents
    • 4.5.1.5.1. Stents market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Traditional Surgery Devices
    • 4.5.2.1. Traditional surgery devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Scalpel
    • 4.5.2.2.1. Scalpel market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3. Forceps
    • 4.5.2.3.1. Forceps market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4. Ophthalmic Scissors
    • 4.5.2.4.1. Ophthalmic scissors market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.5. Punch
    • 4.5.2.5.1. Punch market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.6. Sutures
    • 4.5.2.6.1. Sutures market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.7. Surgical Drapes
    • 4.5.2.7.1. Surgical drapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.8. Microcatheter
    • 4.5.2.8.1. Microcatheter market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.9. Others
    • 4.5.2.9.1. Others market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Diamond Knives
    • 4.5.3.1. Diamond knives market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Laser Systems
    • 4.5.4.1. Laser systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Glaucoma Surgery Devices Market: Surgery Method Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Traditional Glaucoma Surgery
  • 5.1.2. Minimally Invasive Glaucoma Surgery
  • 5.1.3. Laser Surgery
• 5.2. Surgery Method Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Glaucoma Surgery Devices Market by Surgery Method Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Traditional Glaucoma Surgery
    • 5.5.1.1. Traditional glaucoma surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Trabeculectomy
    • 5.5.1.2.1. Trabeculectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Tube Shunt Surgery
    • 5.5.1.3.1. Tube shunt surgery market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Minimally Invasive Glaucoma Surgery
    • 5.5.2.1. Minimally invasive glaucoma surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.2. Trabecular Meshwork Bypass
    • 5.5.2.2.1. Trabecular meshwork bypass market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. Suprachoroidal Space Implants
    • 5.5.2.3.1. Suprachoroidal space implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.4. Subconjunctival Space Implants
    • 5.5.2.4.1. Subconjunctival space implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.5. Schlemm's Canal Implants
    • 5.5.2.5.1. Schlemm's canal implants market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.6. Gonioscopy-assisted Transluminal Trabeculectomy
    • 5.5.2.6.1. Gonioscopy-assisted transluminal trabeculectomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.7. Endocyclophotocoagulation
    • 5.5.2.7.1. Endocyclophotocoagulation market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Laser Surgery
    • 5.5.3.1. Laser surgery market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.2. Trabeculoplasty
    • 5.5.3.2.1. Trabeculoplasty market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.3. Iridotomy
    • 5.5.3.3.1. Iridotomy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3.4. Cyclophotocoagulation
    • 5.5.3.4.1. Cyclophotocoagulation market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Glaucoma Surgery Devices Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Ophthalmic Clinics
  • 6.1.3. Others
• 6.2. End-use Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Glaucoma Surgery Devices Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Ophthalmic Clinics
    • 6.5.2.1. Ophthalmic Clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Others
    • 6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Glaucoma Surgery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2022 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2022
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 7.6. North America
  • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.6.3. Canada
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.7. Europe
  • 7.7.1. UK
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.7.2. Germany
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.7.3. France
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.7.4. Italy
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.7.5. Spain
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.7.6. Denmark
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.7.7. Sweden
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Competitive Scenario
    • 7.7.8.3. Regulatory framework
    • 7.7.8.4. Reimbursement scenario
    • 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.8. Asia Pacific
  • 7.8.1. Japan
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive Scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.8.2. India
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.8.3. China
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.8.4. South Korea
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.8.5. Australia
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.8.6. Thailand
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive Scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement scenario
    • 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.9. Latin America
  • 7.9.1. Brazil
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive Scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.9.2. Mexico
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.9.3. Argentina
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.10. MEA
  • 7.10.1. South Africa
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive Scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement scenario
    • 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.10.2. Saudi Arabia
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive Scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement scenario
    • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.10.3. UAE
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive Scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement scenario
    • 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.10.4. Kuwait
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Competitive Scenario
    • 7.10.4.3. Regulatory framework
    • 7.10.4.4. Reimbursement scenario
    • 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2022
  • 8.3.4. Alcon, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Glaukos Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Johnson & Johnson Vision
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. AbbVie Inc. (Allergan Plc.)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. ASICO, LLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Carl Zeiss Meditec AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Katalyst Surgical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Lumenis Ltd
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Ziemer Ophthalmic Systems AG
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Iridex Corporation
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Altomed
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives

관련자료